We summarise key pharmaceutical, pricing and market access insights that are worth reading about thi...
Read moreAZ has warned its China revenues will decline mid-single-digit percentage in 2022 after years of dou...
Read moreThe HTA initially recommended Tremfya as a treatment option for adults with active psoriatic arthrit...
Read moreThe EUNetHTA recently published its draft scoping guidance which outlines how the contrasting decisi...
Read moreThey came up with six proposals, split into three subgroups, aimed at addressing the key barriers to...
Read moreNICE have been clear that this framework should not be interpreted as minimum standards for real-wor...
Read moreIt is widely expected that the reform will entail the unification of the CTS and the CPR into one bo...
Read moreEUnetHTA and the EU Joint HTA Process EUnetHTA was established in 2006 to facilitate information sha...
Read moreIntroduction Achieving access to patients for innovative treatments is becoming a significant challe...
Read moreThe aim of this trial is to increase capacity, with a goal of a 20% increase by 2023-24.
Read more